MADISON, WIS. – Timothy M. O’Shea, United States Attorney for the Western District of Wisconsin, today announced that Cadott Miller Pharmacy, Ltd., located in Cadott, Wisconsin, has reached a settlement agreement to pay $20,000 to resolve civil allegations that he violated the Controlled Substances Act (CSA) by dispensing controlled substances outside of the usual course of professional pharmacy practice, among other CSA violations.
As a reporter with the U.S. Drug Enforcement Administration (DEA), CSA required the pharmacy to know and follow federal and state laws and regulations regarding the receipt, storage, record keeping, dispensing, distribution and destruction of controlled substances. .
Between 2017 and 2019, the DEA executed several administrative inspection warrants to examine the operations of the pharmacy. As part of the inspections, the DEA investigated the pharmacy’s practices regarding the receipt, distribution, and record keeping of controlled substances. On December 17, 2019, after determining that the pharmacy’s compliance measures had failed, the DEA served an order immediately suspending the pharmacy’s DEA registration certificate, and Cadott Miller Pharmacy voluntarily relinquished its DEA registration on January 7, 2020, for cause. As a result, the pharmacy was unable to dispense controlled substances.
According to government allegations set out in the settlement agreement, Cadott Miller Pharmacy distributed controlled substances outside of the usual course of professional pharmacy practice by filling combinations of controlled substances and drugs that serve no medical purpose. legit, highly addictive, and have been specifically combined to create or enhance abusive and euphoric effects. Additionally, the government alleged that the pharmacy dispensed controlled substances without a valid prescription, provided unauthorized advance refills, and dispensed Schedule II controlled substances for opioid addiction, which is prohibited by federal law.
In enacting the CSA, Congress recognized the importance of preventing the diversion of drugs from legitimate to illegitimate uses. The CSA, in its relevant part, deters the illegal distribution, possession, distribution and use of controlled substances, all of which have contributed significantly to the opioid epidemic over the past two decades. The CSA therefore regulates all entities in the distribution chain, including pharmacies and pharmacists.
“Pharmacies that dispense controlled substances outside of professional pharmacy practice endanger the public, abuse their DEA registration, and violate federal law,” U.S. Attorney O’Shea said. “Pharmacies hold public trust and heavy responsibilities. The overwhelming majority of pharmacies closely adhere to federal and state laws and fully deserve the public’s trust. The U.S. Attorney’s Office, however, will gladly partner with the DEA to protect the public when pharmacies violate federal law.
“The men and women of the DEA, alongside our state and local partners, will continue to protect the citizens of Wisconsin from the reckless and unscrupulous practices of pharmacies that violate the Controlled Substances Act,” John said. G. McGarry, assistant. Special Agent in Charge of the US Drug Enforcement Administration-Wisconsin.
According to the settlement agreement, the amount of the civil penalty was based on an inability to pay a substantial penalty and determined after analysis and review of the pharmacy’s financial situation.
Assistant United States Attorney Leslie Herje represented the government in the case. The DEA’s Milwaukee District Office primarily led the investigation, along with the United States Attorney’s Office’s Positive Civilian Enforcement Team. The Settlement Agreement sets forth CSA’s claims only; Cadott Miller Pharmacy denies the allegations.